Browsing by Author Tonkin, Andrew

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 44 < previous   next >
Issue DateTitleAuthor(s)Citation
2002Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart diseaseMacMahon, Stephen; Neal, Bruce; Brnabic, Alan; Ohkubo, Takayoshi; Tonkin, Andrew; The George Institute for International Health; The George Institute for International HealthEffects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease, Journal Of The Renin-Angiotensin-Aldosterone System, vol.3,(4),2002,pp 270-276
2016Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohortsMitchell, Paul; Woodward, Mark; Adams, Robert J T; Anstey, Kaarin J.; Balkau, Beverley J; Brennan-Olsen, Sharon; Briffa, Tom; Davis, T. M. E.; Davis, Wendy A.; Dobson, Annette; Giles, Graham; Grant, Janet; Harding, Jessica; Huxley, Rachel R; Knuiman, Matthew; Luszcz, Mary; Magliano, Dianna J; Pasco, Julie A.; Reid, Chris; Shaw, Jonathan E; Simmons, D; Simons, Leon; Sooriyakumaran, Manoshayini; Taylor, Anne; Tonkin, Andrew; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global HealthHypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts, Journal of Hypertension, vol.34, 1, 2016,pp 149-155
2010The Inaugural CSANZ Indigenous Cardiovascular Health Conference: Conference Findings and Ways ForwardBrieger, David; Jeremy, Richmond; Kritharides, Leonard; Brown, Alex; Riddell, Tania; Tonkin, Andrew; Walsh, Warren; White, Harvey D.; Zeitz, Chris; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteThe Inaugural CSANZ Indigenous Cardiovascular Health Conference: Conference Findings and Ways Forward, Heart, Lung and Circulation, vol.193, 5-6, 2010,pp 269-272
2009Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID studyKirby, Adrienne; Simes, Robert John; Cui, Jisheng; Forbes, Andrew; Tonkin, Andrew; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLaboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study, European Journal of Cardiovascular Prevention and Rehabilitation, vol.16, 6, 2009,pp 660-668
2009Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID studyBarnes, Elizabeth; Keech, Anthony (Tony); Pollicino, Christine; Simes, Robert John; Colquhoun, David M.; Nestel, Paul; Soderberg, S; Tonkin, Andrew; Yallop, Julie; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreLeptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study, International Journal of Obesity, vol.33,(1),2009,pp 123-130
2013Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-AnalysisKirby, Adrienne; Sullivan, David; Amarenco, Pierre; Arsenault, Benoit J.; Boekholdt, S Matthijs; Colhoun, Helen; DeMicco, David A; et al, Various; Hovingh, G Kees; LaRosa, John C.; Mora, Samia; Pedersen, Terje R; Tonkin, Andrew; Welch, K; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLevels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis, Circulation, vol.128, 14, 2013,pp 1504-1512
2009Maximising the effectiveness and cotst-effectiveness of cardiovascular disease prevention in the general population (Editorial)Colagiuri, Stephen; Tonkin, Andrew; Boyden, Andrew N.; Central Clinical School: Medicine; Medicine Faculty OfficeMaximising the effectiveness and cotst-effectiveness of cardiovascular disease prevention in the general population (Editorial), Medical Journal of Australia, vol.191,(6),2009,pp 300-302
2005National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.Barter, Philip; Sullivan, David; Best, James D.; Boyden, Andrew N.; Clune, Eleanor; Cooper, Catherine; Furler, John S.; Hossack, Ken; Robinson, Malia; Thompson, Peter L.; Tonkin, Andrew; Vale, Margarite; Central Clinical School: Medicine; Molecular & Microbial BioscienNational Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005., Heart Lung and Circulation, vol.14,(4),2005,pp 275-291
2006Neither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study.Pollicino, Christine; Simes, Robert John; Stocker, Roland; Sullivan, David; Colquhoun, David; Gay, Craig A.; Nestel, Paul; Tonkin, Andrew; Whiting, Malcolm; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Medical Sciences: Pathology; School of Molecular BioscienceNeither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study., Atherosclerosis, vol.187,(1),2006,pp 198-204
2012A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?Semsarian, Chris; Sullivan, David; Bishop, Warrick; Clifton, Peter M.; George, Peter M.; Hamilton-Craig, Ian; O'Brien, Richard; Poplawski, Nicola; Tonkin, Andrew; van Bockxmeer, Frank M.; Watts, Gerald F; Central Clinical School: Centenary Institute; School of Public Health: NH&MRC Clinical Trials CentreA New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?, Heart, Lung and Circulation, vol.21, 9, 2012,pp 543-550
2008Parametric conditional frailty models for recurrent cardiovascular events in the lipid studyKirby, Adrienne; Marschner, Ian; Simes, Robert John; Cui, Jisheng; Forbes, Andrew; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreParametric conditional frailty models for recurrent cardiovascular events in the lipid study, Clinical Trials, vol.5,(6),2008,pp 565-574
2017Persistent psychological distress and mortality in patients with stable coronary artery diseaseGlozier, Nicholas; Kirby, Adrienne; Marschner, Simone; Simes, Robert John; Colquhoun, David; Nestel, P; O'Neil, Adrienne; Oldenburg, Brian F.; Stewart, Ralph; Tonkin, Andrew; White, Harvey D; Central Clinical School: Psychological Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePersistent psychological distress and mortality in patients with stable coronary artery disease, Heart, vol.103, 23, 2017,pp 1860-1866
2013Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart DiseaseBarnes, Elizabeth; Fournier, Marion; Simes, Robert John; Blankenberg, Stefan; Colquhoun, David M.; Nestel, Paul; Sullivan, David Richmond; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePlasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, 12, 2013,pp 2902-2908
2015A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease riskBillot, Laurent; Bompoint, Severine; Burch, Carol; Cass, Alan; Hillis, Graham; Jan, Stephen; Neal, Bruce; Patel, Anushka; Peiris, David; Rodgers, Anthony; Usherwood, Timothy; Webster, Ruth; Brown, Alex; Burke, Hugh; Hayman, Noel E.; Molanus, Barbara; Rafter, Natasha; Reid, Chris; Shiel, Louise; Togni, Samantha; Tonkin, Andrew; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; School of Public Health: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Western Clinical School: General Practice; The George Institute for Global HealthA pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk, European Journal of Preventive Cardiology, vol.22, 7, 2015,pp 920-930
2010Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular riskCass, Alan; Jan, Stephen; Neal, Bruce; Patel, Anushka; Rodgers, Anthony; Usherwood, Timothy; Brown, Alex; Burke, Hugh; Eades, Sandra J; Hayman, Noel E.; Liu, Hueiming; Peiris, David; Reid, Chris; Ring, Ian; Stewart, Greg; Tonkin, Andrew; Wade, Vicki; Weeramanthri, Tarun; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; Western Clinical School: General PracticeRationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk, BMC Public Health, vol.10, 1,pp 458-1-458-8
2009Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chartMitchell, Paul (Ronald); Chen, Lei; Dobson, Annette; et al, various; Giles, Graham; Hobbs, Michael; Moon, Lynelle; Phillips, Patrick; Shaw, Jonathon; Simmons, D; Simons, Leon; Tonkin, Andrew; Western Clinical School: Westmead Millennium InstituteRecalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart, European Journal of Cardiovascular Prevention &amp; Rehabilitation, vol.16, 5,pp 562-570
2005Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.Kirby, Adrienne; Mehalski, Kirsty; Pollicino, Christine; Simes, Robert John; Baghurst, Katrine; Colquhoun, David; Nestel, Paul; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Molecular Bioscience; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreRelation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial., American Journal of Clinical Nutrition, vol.81,(6),2005,pp 1322-1329
2010Rheumatic heart disease in indigenous populationsJeremy, Richmond; Kritharides, Leonard; Brieger, David; Brown, Alex; Riddell, Tania; Tonkin, Andrew; Walsh, Warren; White, Harvey D.; Zeitz, Chris; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteRheumatic heart disease in indigenous populations, Heart, Lung and Circulation (Print), vol.19, 5-6,pp 273-281
2003Secondary prevention of cardio vascular events with long-term Pravastatin in patients with diabetes or impared fasting glucoseArulchelvam, Manjula; Baker, Jane; Beller, Elaine; Hague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Simes, Robert John; Best, James D.; Colquhoun, David; Hunt, David; Tonkin, Andrew; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSecondary prevention of cardio vascular events with long-term Pravastatin in patients with diabetes or impared fasting glucose, Diabetes Care, vol.26,(N/A),2003,pp 2713-2721
2010Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID studyKirby, Adrienne; Marschner, Ian; Simes, Robert John; Cui, Jisheng; Forbes, Andrew; Hunt, David; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSemi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study, BMC Medical Research Methodology, vol.10, 27,pp 27-1-27-9